Mutations in PMS2 are linked to Lynch syndrome, which is characterized by early incidence of colorectal cancer, along with increased risk of other malignancies including endometrial, ovarian, small bowel, and brain carcinoma. This evidence concerns the gene PMS2 and Lynch syndrome.